What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Antibody
- Enzyme
The scientist’s investigation covers issues in Immunology, Antibody, Receptor, Complement system and Immune system.
His research in Immunology tackles topics such as Internal medicine which are related to areas like Hereditary angioedema.
His research in Antibody intersects with topics in Molecular biology, Guinea pig and In vivo.
His Receptor research includes elements of Pathology and Complement receptor.
His work in Complement system covers topics such as Microbiology which are related to areas like Bacteria, Complement membrane attack complex and Complement.
Michael M. Frank combines subjects such as Inflammation and Myelin with his study of Immune system.
His most cited work include:
- Treatment of Hereditary Angioedema with Danazol (503 citations)
- Hereditary angioedema: the clinical syndrome and its management. (500 citations)
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema (477 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Immunology, Antibody, Complement system, Molecular biology and Immune system.
His work deals with themes such as Internal medicine and In vivo, which intersect with Immunology.
As part of one scientific family, Michael M. Frank deals mainly with the area of Internal medicine, narrowing it down to issues related to the Hereditary angioedema, and often Pediatrics.
His Antibody research is multidisciplinary, incorporating perspectives in Receptor, Guinea pig and Antigen.
His Complement system research incorporates elements of Opsonin and Microbiology.
His work carried out in the field of Molecular biology brings together such families of science as Cell surface receptor, In vitro, Biochemistry and Hemolysis.
He most often published in these fields:
- Immunology (37.68%)
- Antibody (25.05%)
- Complement system (21.12%)
What were the highlights of his more recent work (between 2003-2021)?
- Hereditary angioedema (12.42%)
- Immunology (37.68%)
- Complement system (21.12%)
In recent papers he was focusing on the following fields of study:
Hereditary angioedema, Immunology, Complement system, C1-inhibitor and Classical complement pathway are his primary areas of study.
His work deals with themes such as Angioedema, Ecallantide, Surgery and Pediatrics, which intersect with Hereditary angioedema.
Michael M. Frank works mostly in the field of Immunology, limiting it down to topics relating to Disease and, in certain cases, Abdominal pain, as a part of the same area of interest.
The Complement system study combines topics in areas such as Molecular biology and Biochemistry.
His Classical complement pathway study integrates concerns from other disciplines, such as Cell biology, Complement membrane attack complex and Complement receptor.
His research integrates issues of Inflammation and Antigen in his study of Immune system.
Between 2003 and 2021, his most popular works were:
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema (477 citations)
- Practice parameter for the diagnosis and management of primary immunodeficiency. (441 citations)
-
- Hereditary angioedema. (356 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Antibody
- Enzyme
Michael M. Frank mostly deals with Immunology, Hereditary angioedema, Complement system, Ecallantide and C1-inhibitor.
Immune system, Innate immune system, Factor H, Primary immunodeficiency and Complement factor B are among the areas of Immunology where the researcher is concentrating his efforts.
His Hereditary angioedema research is multidisciplinary, incorporating perspectives in Disease, C1 inhibitor deficiency, Angioedema, Abdominal pain and Pediatrics.
Michael M. Frank interconnects Molecular biology and Antibody opsonization in the investigation of issues within Complement system.
His Ecallantide research incorporates themes from Randomized controlled trial, Gynecology and Edema.
His study in C1-inhibitor is interdisciplinary in nature, drawing from both Activities of daily living, Burden of disease, Surgery and Immunopathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
